Annual Report And Financial Statements

Overview

The report describes how the company integrates ESG considerations into investment due diligence and monitoring, focusing on health, innovation, inequality and partnerships through SDGs 3, 9, 10 and 17. It reports executive-level ESG oversight through a CEO-led ESG committee and highlights the ESG practices of the investment manager. For BioPharma Credit PLC itself, the report states that it has no employees or premises and no direct operational GHG emissions, with energy consumption below 40,000 kWh for the year. It also reports a five-member board with one female director, or 20%.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2022
Period: 1 January 2022 – 31 December 2022
Publication date: 21 March 2023
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services